Manufacturing hurdles are just one challenge the industry must overcome to commercialize personalized mRNA cancer vaccines.

Gilead’s new “Up to Date” campaign uses humor and dating scenarios to reach Black communities amid persistent gaps in HIV ...

Merck is testing whether pairing antibody-drug conjugates with Keytruda can improve treatment for breast and gynecologic cancers while helping the company prepare for its biggest drug’s patent cliff.

Oncology still accounts for nearly two out of five pipeline drugs, while obesity entered the top 10 indications and one-third ...

CAR-T’s commercial challenge isn’t making bigger batches. It’s making thousands of patient-specific manufacturing runs behave ...

The Alzheimer’s space has really got a fire under it,” says one analyst. But can the momentum deliver better drugs?

Wall Street analysts believe that a more cautious approach to manufacturing, study enrollment and side effect management ...

Success in women’s oncology isn’t just about buying patients more time but making those added months or years feel as close to normal as possible, according to Dr. Shweta Jain, vice president of ...

Plump joined Takeda during a turbulent period, pushed the company to work more closely with young biotechs and will leave it ...

After two notable failures, the social anxiety R&D space gained a major player when Eli Lilly agreed to acquire AtaiBeckley ...